成人院外心脏骤停中骨髓腔内与静脉通路比较:整群随机临床试验(VICTOR试验)
VICTOR整群随机对照试验在台北市4个高级生命支持救护队中比较成人非创伤性院外心脏骤停时骨髓腔内与静脉通路的效果,纳入1771例患者,主要终点出院存活率在骨髓腔内组为10.7%、静脉组为10.3%(OR 1.04,95%CI 0.76-1.42;P=0.81),组间无显著差异。
要点
- 骨髓腔内与静脉通路组出院存活率分别为10.7%与10.3%,OR 1.04(95%CI 0.76-1.42;P=0.81)。
- 院前自主循环恢复、持续自主循环恢复及良好神经功能存活率组间均无显著差异。
- 成人非创伤性院外心脏骤停中,初始骨髓腔内通路与静脉通路结局无差异。
核心结论
- 在成人非创伤性院外心脏骤停中,初始尝试骨髓腔内通路与静脉通路在出院存活率、院前自主循环恢复、持续自主循环恢复及良好神经功能结局方面无显著差异。
研究设计与样本
- 整群随机对照试验,纳入台北市全部4个高级生命支持救护队,入组期为2020年7月6日至2023年6月30日,因COVID-19疫情于2021年5月20日至2021年7月31日暂停。
- 纳入年龄20-80岁的非创伤性院外心脏骤停成人患者,每两周将4个救护队随机分配至骨髓腔内或静脉通路组。
- 共1771例患者入组,1732例纳入主要分析(骨髓腔内组741例,静脉组991例;中位年龄65.0岁;男性1234例,占71.2%)。
主要发现
- 骨髓腔内组79例(10.7%)出院存活,静脉组102例(10.3%)出院存活(OR 1.04,95%CI 0.76-1.42;P=0.81)。
- 院前自主循环恢复的OR为1.23(95%CI 0.89-1.69;P=0.21)。
- 持续自主循环恢复(≥2小时)的OR为0.92(95%CI 0.75-1.13;P=0.44)。
- 出院时良好神经功能结局(脑功能分级评分≤2)存活的OR为1.17(95%CI 0.82-1.66;P=0.39)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the effectiveness of intraosseous versus intravenous vascular access in the treatment of adult patients with out-of-hospital cardiac arrest. DESIGN: Cluster randomised controlled trial. SETTING: The VICTOR (Venous Injection Compared To intraOsseous injection during resuscitation of patients with out-of-hospital cardiac arrest) trial involved emergency medical service agencies with all four advanced life support ambulance teams in Taipei City, Taiwan. The enrolment period spanned 6 July 2020 to 30 June 2023 and was temporarily suspended between 20 May 2021 and 31 July 2021 owing to the covid-19 pandemic. PARTICIPANTS: Adult (age 20-80 years) patients with non-traumatic out-of-hospital cardiac arrest. INTERVENTIONS: Biweekly randomised clusters of four participating advanced life support ambulance teams were assigned to insert either intravenous or intraosseous access. MAIN OUTCOME MEASURES: The primary outcome was survival to hospital discharge. Secondary outcomes included return of spontaneous circulation, sustained return of spontaneous circulation (≥2 hours), and survival with favourable neurological outcomes (cerebral performance category score ≤2) at hospital discharge. RESULTS: Among 1771 enrolled patients, 1732 (741 in the intraosseous group and 991 in the intravenous group) were included in the primary analysis (median age 65.0 years; 1234 (71.2%) men). In the intraosseous group, 79 (10.7%) patients were discharged alive, compared with 102 (10.3%) patients in the intravenous group (odds ratio 1.04, 95% confidence interval 0.76 to 1.42; P=0.81). The odds ratio of intraosseous versus intravenous access was 1.23 (0.89 to 1.69; P=0.21) for pre-hospital return of spontaneous circulation, 0.92 (0.75 to 1.13; P=0.44) for sustained return of spontaneous circulation, and 1.17 (0.82 to 1.66; P=0.39) for survival with favourable neurological outcomes. CONCLUSIONS: Among adults with non-traumatic out-of-hospital cardiac arrest, initial attempts to establish vascular access through the intraosseous route did not result in different outcomes compared with intravenous access in terms of the proportion of patients surviving to hospital discharge, pre-hospital return of spontaneous circulation, sustained return of spontaneous circulation, and favourable neurological outcomes. TRIAL REGISTRATION: NCT04135547ClinicalTrials.gov NCT04135547.
引用
- Ko YC, Lin HY, Huang EP, et al. Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial). BMJ. 2024. PMID: 39043416. doi:10.1136/bmj-2024-079878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。